ClinicalTrials.Veeva

Menu

Cytokine Assay in Tears of Healthy Children and With Vernal Keratoconjunctivitis: Case Control Study and Monitoring of Cases at 6 Months

U

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

Healthy Children
Vernal Keratoconjunctivitis

Treatments

Procedure: Cytokins assay in tears

Study type

Observational

Funder types

Other

Identifiers

NCT02057822
2012-A00034-39
CHU-0170

Details and patient eligibility

About

The ocular surface may be the seat of an inflammatory process in many pathology as vernal keratoconjunctivitis. It has been shown that inflammatory cytokines produced by the cells themselves and the constituent cells of the target organ, are the main factors that cause inflammation. The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects.

Full description

The ocular surface may be the seat of an inflammatory process in many pathology as vernal keratoconjunctivitis. It has been shown that inflammatory cytokines produced by the cells themselves and the constituent cells of the target organ, are the main factors that cause inflammation. The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects.

Enrollment

60 estimated patients

Sex

All

Ages

3 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Childrens between 3 and 18 years
  • Affiliated at system of French social security
  • Signed by the holders of parental authority of the sheet and written consent to participate in this study
  • First consultation at Clermont-Ferrand Hospital for vernal keratocunjunctivitis

Exclusion criteria

  • Subject suffering from acute or chronic eye disease in which the physician investigator resound with the results: uveitis, glaucoma, retinopathy
  • Subject who had undergone eye surgery
  • Subject having an infection the day of collection: ENT, digestive, urinary
  • Subject with cancer, mental illness or any other condition in which the physician investigator sound informed consent and / or the results
  • Pregnant subject
  • Subject with contact lenses
  • Subject who judged by the investigating physician not enough cooperating to allow a safe collection

Trial design

60 participants in 2 patient groups

vernal keratoconjunctivitis
Description:
The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjonctivitis and in control subjects
Treatment:
Procedure: Cytokins assay in tears
healthy children
Description:
The main objective of our study was to compare the concentration of 40 cytokines in vernal keratoconjunctivitis and in control subjects
Treatment:
Procedure: Cytokins assay in tears

Trial contacts and locations

1

Loading...

Central trial contact

Patrick LACARIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems